Cardiovascular Risk Factors in Hypertension, Dyslipidemia, and Arterial Hypotension: A Clinical Overview
DOI:
https://doi.org/10.51699/cajmns.v6i4.2996Keywords:
Hypertension, Dyslipidemia, Combined Dyslipidemia, Arterial Hypotension, Cardiovascular Risk Factors, Autonomic Nervous SystemAbstract
Cardiovascular diseases (CVD) continue to be a leading cause of morbidity and mortality worldwide. Early identification of modifiable and non-modifiable risk factors is crucial for the effective prevention of cardiovascular complications. This article synthesizes findings from three studies: assessment of cardiovascular risk factors in patients with hypertension and cerebral circulatory disorders, evaluation of the prevalence of arterial hypertension among patients with combined dyslipidemia, and investigation of the relationship between peripheral blood flow and autonomic nervous system activity in young women with idiopathic arterial hypotension. The combined analysis highlights the significance of early risk detection, comorbidity management, and individualized therapeutic approaches to improve patient outcomes and reduce the burden of cardiovascular disease.
References
A. V. Chobanian, G. L. Bakris, H. R. Black et al., "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)," Hypertension, vol. 42, pp. 1206–1252, 2003.
D. M. Lloyd-Jones, J. C. Evans, M. G. Larson et al., "Differential impact of blood pressure and cardiovascular risk factors by age and sex," JAMA, vol. 294, pp. 898–904, 2005.
S. M. Grundy, N. J. Stone, A. L. Bailey et al., "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol," Circulation, vol. 139, pp. e1082–e1143, 2019.
P. M. Kearney, M. Whelton, K. Reynolds et al., "Global burden of hypertension: analysis of worldwide data," Lancet, vol. 365, pp. 217–223, 2005.
W. H. Frishman, "Pathophysiology and clinical management of dyslipidemia," Cardiol. Rev., vol. 18, pp. 67–74, 2010.
P. Palatini and S. Julius, "Autonomic dysfunction in arterial hypotension and its cardiovascular implications," Hypertension, vol. 30, pp. 1037–1042, 1997.
Y. Shimizu, T. Hashimoto, T. Ishii et al., "Role of autonomic nervous system in idiopathic arterial hypotension in young women," Clin. Auton. Res., vol. 12, pp. 179–184, 2002.
S. Yusuf, S. Hawken, S. Ôunpuu et al., "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study," Lancet, vol. 364, pp. 937–952, 2004.
B. Williams, G. Mancia, W. Spiering et al., "2023 ESC/ESH Guidelines for the management of arterial hypertension," Eur. Heart J., vol. 44, pp. 1759–1852, 2023.
P. Palatini and G. Reboldi, "Hypertension and the risk of cardiovascular disease in different populations: the role of dyslipidemia," Curr. Opin. Cardiol., vol. 27, pp. 410–416, 2012.
A. V. Poznyak, N. K. Sadykhov, A. G. Kartuesov et al., "Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment," Front. Cardiovasc. Med., vol. 9, Art. no. 959285, 2022.
J. J. Dalal, T. N. C. Padmanabhan, P. Jain, S. Patil, H. Vasnawala, and A. Gulati, "LIPITENSION: Interplay between dyslipidemia and hypertension," Indian J. Endocrinol. Metab., vol. 16, no. 2, pp. 240–245, 2012.
J. Wyszyńska, E. Łuszczki, G. Sobek, A. Mazur, and K. Dereń, "Association and risk factors for hypertension and dyslipidemia in young adults from Poland," Int. J. Environ. Res. Public Health, vol. 20, no. 2, p. 982, 2023.
S. E. Kjeldsen, "Hypertension and cardiovascular risk: General aspects," Pharmacol. Res., vol. 129, pp. 95–99, 2018.
P. Jeemon, R. Gupta, C. Onen, A. Adler, T. A. Gaziano, D. Prabhakaran, and N. Poulter, "Management of hypertension and dyslipidemia for primary prevention of cardiovascular disease," Unpublished, 2018.
